Stable Coronary Artery Disease Clinical Trial
Official title:
Des Re-Endothelization for In-StEnt ResTenosis. The DESERT Study
The hypothesis of this study is that strut coverage occurs earlier when a DES is implanted to treat a BMS restenosis compared with atherosclerotic de-novo lesion. This hypothesis is supported by two different observations: first, when a DES is implanted to treat a BMS restenosis, stent struts are deployed and drugs are eluted on a soft tissue mostly characterized by extracellular matrix with a regular surface. In this case stent malposition is less likely to occur compared to atherosclerotic lesion whose surface is often more irregular and rich in calcium. Second, patients who develop in-stent restenosis after BMS implantation are likely to show a more pronounced neointima hyperplasia and, when a DES is implanted to treat restenosis, reendothelialization is likely to occur earlier. If this hypothesis was verified, duration of dual antiplatelet therapy could be shortened after DES implantation on BMS restenosis with a clinical advantage in terms of bleeding risk. Furthermore, a higher bleeding risk is often a reason for choosing a BMS instead of a DES; thus, patients presenting with BMS restenosis are likely to have a higher bleeding risk and to benefit from a shorter period of dual antiplatelet therapy.
n/a
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01205425 -
Computed Tomography Coronary Angiography Before Stent Implantation
|
N/A | |
| Completed |
NCT03312855 -
Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept
|
Phase 2 | |
| Completed |
NCT00642811 -
A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders
|
Phase 2 | |
| Recruiting |
NCT03089450 -
To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent
|
N/A | |
| Completed |
NCT01523392 -
A Pharmacodynamic Study With Ticagrelor in African American Patients
|
Phase 4 | |
| Completed |
NCT01209637 -
Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CAD
|
N/A | |
| Active, not recruiting |
NCT04434365 -
Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT00510588 -
Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
|
N/A | |
| Completed |
NCT03384966 -
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
|
Phase 2 | |
| Active, not recruiting |
NCT01609465 -
Prognostic Models for People With Stable Coronary Artery Disease
|
N/A | |
| Terminated |
NCT00911339 -
Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents
|
Phase 3 | |
| Completed |
NCT00984802 -
Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy
|
Phase 2 | |
| Completed |
NCT03782688 -
Precise Percutaneous Coronary Intervention Plan (P3) Study
|
||
| Completed |
NCT02580851 -
Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention
|
N/A | |
| Recruiting |
NCT03313752 -
Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity
|
Phase 3 | |
| Completed |
NCT01184300 -
ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
|
Phase 2/Phase 3 | |
| Completed |
NCT01523366 -
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
|
Phase 4 | |
| Completed |
NCT01118325 -
An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
|
Phase 2 | |
| Recruiting |
NCT06123728 -
MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease
|